V61L (p.Val61Leu) variant of ADCY5 (Adenylate cyclase type 5)
V61L (p.Val61Leu) in ADCY5 (Adenylate cyclase type 5) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.25 / 1. The record also includes population frequency data and structural context.
V61L (p.Val61Leu) variant details
- p.Val61Leu
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.253
- REVEL 0.11
- MetaLR 0.18
- MetaSVM -0.78
- CADD 16.40
- PolyPhen-2 0.26
- SIFT 0.16
- UniProt: Variant assessed as somatic; moderate impact.
- Population evidence available
- Structural context available